MicroRNA-425 promotes the development of lung adenocarcinoma via targeting A disintegrin and metalloproteinases 9 (ADAM9)

References

• JemalABrayFCenterMMFerlayJWardEFormanDGlobal cancer statisticsCA Cancer J Clin2011612699021296855
   PubMed Web of Science ®Google Scholar
• SèvePReimanTDumontetCThe role of betaIII tubulin in predicting chemoresistance in non-small cell lung cancerLung Cancer201067213614319828208
   PubMed Web of Science ®Google Scholar
• ThomsonCSFormanDCancer survival in England and the influence of early diagnosis: what can we learn from recent EUROCARE results?Br J Cancer2009101Suppl 2S102S10919956153
   PubMed Web of Science ®Google Scholar
• ImielinskiMBergerAHHammermanPSMapping the hallmarks of lung adenocarcinoma with massively parallel sequencingCell201215061107112022980975
   PubMed Web of Science ®Google Scholar
• FaraziTAHoellJIMorozovPMicroRNAs in human cancerSchmitzUWolkenhauerOVeraJMicroRNA Cancer RegulationBerlinSpringer2013120
   Google Scholar
• TüfekciKUMeuwissenRLGençSThe role of microRNAs in biological processesMethods Mol Biol20141107153124272429
   PubMedGoogle Scholar
• RoybalJDZangYAhnYHmiR-200 inhibits lung adenocarcinoma cell invasion and metastasis by targeting Flt1/VEGFR1Mol Cancer Res201191253521115742
   PubMed Web of Science ®Google Scholar
• SongQXuYYangCmiR-483-5p promotes invasion and metastasis of lung adenocarcinoma by targeting RhoGDI1 and ALCAMCancer Res201474113031304224710410
   PubMed Web of Science ®Google Scholar
• CaiJWuJZhangHmiR-186 downregulation correlates with poor survival in lung adenocarcinoma, where it interferes with cell-cycle regulationCancer Res201373275676623204228
   PubMed Web of Science ®Google Scholar
• WangHZhuLWangRYangYCWangZXMiR-224 promotes the chemoresistance of human lung adenocarcinoma cells to cisplatin via regulating G 1/S transition and apoptosis by targeting p21 WAF1/CIP1Br J Cancer2014111233935424921914
   PubMed Web of Science ®Google Scholar
• LiJWangYSongYFuZYuWmiR-27a regulates cisplatin resistance and metastasis by targeting RKIP in human lung adenocarcinoma cellsMol Cancer20141319325128483
   PubMed Web of Science ®Google Scholar
• LiuLZhaoZZhouWFanXZhanQSongYEnhanced expression of miR-425 promotes esophageal squamous cell carcinoma tumorigenesis by targeting SMAD2J Genet Genomics2015421160161126674378
   PubMed Web of Science ®Google Scholar
• LiuPHuYMaLDuMXiaLHuZmiR-425 inhibits melanoma metastasis through repression of PI3K-Akt pathway by targeting IGF-1Biomed Pharmacother201575515526463631
   PubMed Web of Science ®Google Scholar
• HeBLiTGuanLCTNNA3is a tumor suppressor in hepatocellular carcinomas and is inhibited by miR-425Oncotarget2016778078808926882563
   PubMedGoogle Scholar
• WolfsbergTGPrimakoffPMylesDGWhiteJMADAM, a novel family of membrane proteins containing A Disintegrin And Metallo-protease domain: multipotential functions in cell-cell and cell-matrix interactionsJ Cell Biol199513122752787593158
   PubMed Web of Science ®Google Scholar
• ScanlanMJGordonCMWilliamsonBIdentification of cancer/testis genes by database mining and mRNA expression analysisInternational Journal of Cancer200298448549211920606
   PubMed Web of Science ®Google Scholar
• LinCYChenHJHuangCCADAM9 promotes lung cancer metastases to brain by a plasminogen activator-based pathwayCancer Res201474185229524325060522
   PubMed Web of Science ®Google Scholar
• ChangLGongFCaiHLiZCuiYCombined RNAi targeting human Stat3 and ADAM9 as gene therapy for non-small cell lung cancerOncol Lett20161121242125026893726
   PubMed Web of Science ®Google Scholar
• LivakKJSchmittgenTDAnalysis of relative gene expression data using RT-qPCR and the 2−ΔΔCT methodMethods20012540240811846609
   PubMed Web of Science ®Google Scholar
• AcunzoMRomanoGWernickeDCroceCMMicroRNA and cancer – a brief overviewAdv Biol Regul2015571925294678
   PubMedGoogle Scholar
• ChengGCirculating miRNAs: roles in cancer diagnosis, prognosis and therapyAdv Drug Deliv Rev201581759325220354
   PubMed Web of Science ®Google Scholar
• FlorczukMSzpechcinskiAChorostowska-WynimkoJmiRNAs as biomarkers and therapeutic targets in non-small cell lung cancer: current perspectivesTarget Oncol201712212227510230
   PubMed Web of Science ®Google Scholar
• ChoWCMicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapyInt J Biochem Cell Biol20104281273128120026422
   PubMed Web of Science ®Google Scholar
• HodgeDRHurtEMFarrarWLThe role of IL-6 and STAT3 in inflammation and cancerEur J Cancer200541162502251216199153
   PubMed Web of Science ®Google Scholar
• ChangQBournazouESansonePThe IL-6/JAK/Stat3 feed-forward loop drives tumorigenesis and metastasisNeoplasia201315784886223814496
   PubMed Web of Science ®Google Scholar
• GrivennikovSIGretenFRKarinMImmunity, inflammation, and cancerCell2010140688389920303878
   PubMed Web of Science ®Google Scholar
• YehHHLaiWWChenHHLiuHSSuWCAutocrine IL-6-induced Stat3 activation contributes to the pathogenesis of lung adenocarcinoma and malignant pleural effusionOncogene200625314300430916518408
   PubMed Web of Science ®Google Scholar
• YangXLiangLZhangXFMicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathwayHepatology201358115817023389848
   PubMed Web of Science ®Google Scholar
• WildeboerDNausSAmy sangQXBartschJWPagenstecherAMetalloproteinase disintegrins ADAM8 and ADAM19 are highly regulated in human primary brain tumors and their expression levels and activities are associated with invasivenessJ Neuropathol Exp Neurol200665551652716772875
   PubMed Web of Science ®Google Scholar
• ReissKSaftigPThe “a disintegrin and metalloprotease” (ADAM) family of sheddases: physiological and cellular functionsSemin Cell Dev Biol200920212613719049889
   PubMed Web of Science ®Google Scholar
• MochizukiSOkadaYADAMs in cancer cell proliferation and progressionCancer Sci200798562162817355265
   PubMed Web of Science ®Google Scholar
• TurnerSLBlair-ZajdelMEBunningRAADAMs and ADAMTSs in cancerBr J Biomed Sci200966211719637655
   PubMed Web of Science ®Google Scholar
• Carl-McGrathSLendeckelUEbertMRoessnerARöckenCThe disintegrin-metalloproteinases ADAM9, ADAM12, and ADAM15 are upregulated in gastric cancerInt J Oncol2005261172415586220
   PubMed Web of Science ®Google Scholar
• KimJMJeungHCRhaSYThe effect of disintegrin-metalloproteinase ADAM9 in gastric cancer progressionMol Cancer Ther201413123074308525344581
   PubMed Web of Science ®Google Scholar
• LiJJiZQiaoCQiYShiWOverexpression of ADAM9 promotes colon cancer cells invasionJ Invest Surg201326312713326981956
   PubMedGoogle Scholar
• ShintaniYHigashiyamaSOhtaMOverexpression of ADAM9 in non-small cell lung cancer correlates with brain metastasisCancer Res200464124190419615205330
   PubMed Web of Science ®Google Scholar
• SherYPWangLJChuangLLADAM9 up-regulates N-cadherin via miR-218 suppression in lung adenocarcinoma cellsPLoS One201494e9406524705471
   PubMed Web of Science ®Google Scholar
• LinCYChenHJHuangCCADAM9 promotes lung cancer metastases to brain by a plasminogen activator-based pathwayCancer Res201474185229524325060522
   PubMed Web of Science ®Google Scholar